Clark Capital Management Group Inc. Lowers Holdings in Danaher Corporation $DHR

Posted by Stanley Muller on Jun 17th, 2026

Clark Capital Management Group Inc. decreased its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 1.5% in the fourth quarter, Holdings Channel reports. The firm owned 222,161 shares of the conglomerate’s stock after selling 3,380 shares during the quarter. Clark Capital Management Group Inc.’s holdings in Danaher were worth $50,857,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter worth $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter worth $27,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth $25,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher in the second quarter worth $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of Danaher stock opened at $181.57 on Wednesday. The stock’s 50-day simple moving average is $180.54 and its 200-day simple moving average is $203.94. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a market capitalization of $128.51 billion, a price-to-earnings ratio of 35.12, a PEG ratio of 2.31 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period in the previous year, the business earned $1.88 earnings per share. The business’s revenue was up 3.7% on a year-over-year basis. As a group, analysts expect that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Analysts Set New Price Targets

DHR has been the subject of several research analyst reports. Citigroup initiated coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective for the company. TD Cowen cut their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Royal Bank Of Canada initiated coverage on Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price objective for the company. Finally, DZ Bank initiated coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $233.61.

Check Out Our Latest Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.